Bone-targeting engineered small extracellular vesicles carrying anti-miR-6359-CGGGAGC prevent valproic acid-induced bone loss

Bone-targeting engineered small extracellular vesicles carrying anti-miR-6359-CGGGAGC prevent valproic acid-induced bone loss

Abstract The clinical role and underlying mechanisms of valproic acid (VPA) on bone homeostasis remain controversial. Herein, we confirmed that VPA treatment was associated with decreased bone mass and bone mineral density (BMD) in both patients and mice. This effect was attributed to VPA-induced el...

Full description

Bibliographic Details
Main Authors: Xudong Xie, Peng Cheng, Liangcong Hu, Wu Zhou, Detai Zhang, Samuel Knoedler, Guodong Liu, Yuan Xiong, Hang Xue, Yiqiang Hu, Barbara Kern, Doha Obed, Adriana C. Panayi, Lang Chen, Chenchen Yan, Ze Lin, Guandong Dai, Bobin Mi, Yingze Zhang, Guohui Liu
Format: Article
Language:English
Published: Nature Publishing Group 2024-01-01
Series:Signal Transduction and Targeted Therapy
Online Access:https://doi.org/10.1038/s41392-023-01726-8

Internet

https://doi.org/10.1038/s41392-023-01726-8

Similar Items